Same pattern in biotechs is seen over and over...
Big gains coming, $15-$20 within 4 months
I can see a run up to ASCO, but I don't see the $15-$20 range.
Of course, my predictions are usually off, so I hope your right.
....and reputation on a two-bit tiny biotech company? Because he knows it will be a blockbuster. Positive ENCHANT, positive CHIARA, great Galaxy1final data-- all by year's end, pps $20
Why would Ramachandra waste his time n
Will SNTA have a new abstracts to present? I thought the deadline for abstracts was April 1. Anyone know?